Concepedia

Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients

S Brost

World Journal of Gastroenterology · 2010 · 33 citations · 16 references

DOIFull text

Open access

Abstract

ETV seems to be effective and safe treatment for HBV reactivation. Monitoring of quantitative HBsAg might be an additional useful tool to monitor treatment response.

References

16

EASL clinical practice guidelines management of chronic hepatitis B

张学武, Xu Li · Inter J Epidemiol Infect Dis · 2009 · 1.5K citations

, , +6

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

Journal of Hepatology · 2008 · 1.3K citations

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Ching‐Lung Lai, Daniel Shouval, Anna S. Lok et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients #

Rami Moucari, Vincent Mackiewicz, Olivier Lada et al. · Hepatology · 2008 · 480 citations · Full text

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

Jerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn et al. · Journal of Hepatology · 2010 · 399 citations

, , +10